McKesson Corporation (MCK) has been positioned as one of the best value dividend stocks to buy by billionaires and analyst Jim Cramer, who labeled the healthcare giant a 'Money Machine.' A notable development includes the complete acquisition of PRISM Vision Holdings, a move that signifies McKesson's intent to become a leader in the ophthalmology field. Further solidifying this intent, McKesson has also launched the Precision Care Initiative aimed at transforming oncology treatment. Despite market fluctuations, McKesson's revenue growth remains strong, a factor that is contributing to its escalating stock price. The potential for future revenue growth is also seen through McKesson's strategic divestiture of Canada-Based businesses, Rexall and Well.ca, further concentrating efforts on oncology and biopharma growth. Despite occasional earnings and sales misses and potential downside risks, McKesson's EPS has exceeded expectations, playing a role in its sustained rally. McKesson's 80% interest in PRISM Vision for approximately $850M could be seen as a defining move.
Mckesson Corporation MCK News Analytics from Wed, 07 Aug 2024 07:00:00 GMT to Fri, 18 Apr 2025 21:34:29 GMT -
Rating 7
- Innovation 4
- Information 8
- Rumor -4
